I

MiNK Therapeutics
D

INKT

11.460
USD
0.25
(2.23%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
53,795,016
الأخبار المقالات

العنوان: MiNK Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.